MedTrace Logo

Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study

NCT04179747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-11-29

No results posted yet for this study

Summary

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with two arms involving a control group. The study was conducted with an aim of pilot and feasibility study to evaluate the efficacy and suitability of cognitive behavior psychotherapy with individuals suffering from erectile dysfunction.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Psychotherapy

The Cognitive Behavior Psychotherapy was provided for a period of maximum 3 months.

DRUG

Sildenafil Citrate 50Mg Tab

The participants in control group arm received Sildenafil Citrate 50mg tablet on demand for a period of maximum 3 months.

Sponsors & Collaborators

  • International Islamic University, Islamabad

    lead OTHER

Principal Investigators

  • Ahmad Bilal, MPhil · International Islamic University, Islamabad, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2018-07-24
Completion
2018-07-24

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04179747 on ClinicalTrials.gov